Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral fosfomycin step-down therapy for ESBL-producing Escherichia coli upper urinary tract infection
TCTR20171021001Phase 3Recruiting
- Sponsor
- Mahidol University
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosfomycin in pyelonephritis, sponsored by Mahidol University. Started Mar 2018; status: recruiting.
02
Drugs
fosfomycin
03
Conditions
pyelonephritis
Beyond the preview
Go deeper on TCTR20171021001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171021001.